메뉴 건너뛰기




Volumn 21, Issue 4, 2000, Pages 697-701

Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; RATING SCALE; SUBSTANTIA NIGRA;

EID: 0034078533     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (114)

References (20)
  • 1
    • 0010370534 scopus 로고    scopus 로고
    • Familial Parkinson's disease
    • Duvoisin RC. Familial Parkinson's disease. Neurosci News 1998;1:43-46
    • (1998) Neurosci News , vol.1 , pp. 43-46
    • Duvoisin, R.C.1
  • 2
    • 0031781651 scopus 로고    scopus 로고
    • Adenovirus in the brain: Recent advances in gene therapy for neurodege-nerative diseases
    • Barkats M, Bilang-Bleuel A, Buc-Caron MH, et al. Adenovirus in the brain: recent advances in gene therapy for neurodege-nerative diseases. Prog Neurobiol 1998;55:333-341
    • (1998) Prog Neurobiol , vol.55 , pp. 333-341
    • Barkats, M.1    Bilang-Bleuel, A.2    Buc-Caron, M.H.3
  • 3
    • 0033058906 scopus 로고    scopus 로고
    • Restorative gene therapy approaches to Parkinson's disease
    • Freese A. Restorative gene therapy approaches to Parkinson's disease. Med Clin North Am 1999;83:537-548
    • (1999) Med Clin North Am , vol.83 , pp. 537-548
    • Freese, A.1
  • 4
    • 0000224448 scopus 로고
    • Unified Parkinson's disease rating scale
    • Fahn S, Marsden CD, Calne D, Goldstein M, eds. Florham Park, NJ: Macmillan Press
    • Fahn S, Elton ER. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Press;1987:293-304
    • (1987) Recent Developments in Parkinson's Disease , pp. 293-304
    • Fahn, S.1    Elton, E.R.2
  • 5
    • 0030696234 scopus 로고    scopus 로고
    • Motor disturbance and brain functional imaging in Parkinson's disease
    • Brooks DJ. Motor disturbance and brain functional imaging in Parkinson's disease. Eur Neurol 1997;38[suppl]:26-32
    • (1997) Eur Neurol , vol.38 , Issue.SUPPL. , pp. 26-32
    • Brooks, D.J.1
  • 6
    • 0029348624 scopus 로고
    • The use of PET in Parkinson's disease
    • Shinotoh H, Calne DB. The use of PET in Parkinson's disease. Brain Cogn 1995;28:297-301
    • (1995) Brain Cogn , vol.28 , pp. 297-301
    • Shinotoh, H.1    Calne, D.B.2
  • 7
    • 0028271363 scopus 로고
    • Separating Parkinson's disease from normality: Discriminant function analysis of fluorodopa F 18 positron emission tomography data
    • Sawle GV, Playford ED, Burn DJ, Cunningham VJ, Brooks DJ. Separating Parkinson's disease from normality: discriminant function analysis of fluorodopa F 18 positron emission tomography data. Arch Neurol 1994;51:237-243
    • (1994) Arch Neurol , vol.51 , pp. 237-243
    • Sawle, G.V.1    Playford, E.D.2    Burn, D.J.3    Cunningham, V.J.4    Brooks, D.J.5
  • 8
    • 0027208559 scopus 로고
    • The detection of preclinical Parkinson's disease: What is the role of positron emission tomography?
    • Sawle GV. The detection of preclinical Parkinson's disease: what is the role of positron emission tomography? Mov Disord 1993;8:271-277
    • (1993) Mov Disord , vol.8 , pp. 271-277
    • Sawle, G.V.1
  • 9
    • 0031684335 scopus 로고    scopus 로고
    • Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients
    • Seibyl JP, Marek K, Sheff K, et al. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med 1998;39:1500-1508
    • (1998) J Nucl Med , vol.39 , pp. 1500-1508
    • Seibyl, J.P.1    Marek, K.2    Sheff, K.3
  • 10
    • 0029094141 scopus 로고
    • Decreased SPECT beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease
    • Seibyl JP, Marek KL, Quinlan D, et al. Decreased SPECT beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995;38:589-598
    • (1995) Ann Neurol , vol.38 , pp. 589-598
    • Seibyl, J.P.1    Marek, K.L.2    Quinlan, D.3
  • 11
    • 0028972223 scopus 로고
    • Evaluation of beta-CIT with SPECT in controls, early and late Parkinson's disease
    • Vermeulen RJ, Wolters EC, Tissingh G, et al. Evaluation of beta-CIT with SPECT in controls, early and late Parkinson's disease. Nucl Med Biol 1995;22:985-991
    • (1995) Nucl Med Biol , vol.22 , pp. 985-991
    • Vermeulen, R.J.1    Wolters, E.C.2    Tissingh, G.3
  • 12
    • 0028998624 scopus 로고
    • Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease
    • Gorell JM, Ordidge RJ, Brown GG, Deniau JC, Buderer NM, Helpern JA. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995;45:1138-114 3 [published erratum appears in Neurology 1995;45:1420 ]
    • (1995) Neurology , vol.45 , pp. 1138-1143
    • Gorell, J.M.1    Ordidge, R.J.2    Brown, G.G.3    Deniau, J.C.4    Buderer, N.M.5    Helpern, J.A.6
  • 13
    • 0029090258 scopus 로고
    • Gorell JM, Ordidge RJ, Brown GG, Deniau JC, Buderer NM, Helpern JA. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995;45:1138-114 3 [published erratum appears in Neurology 1995;45:1420 ]
    • (1995) Neurology , vol.45 , pp. 1420
  • 14
    • 0028142827 scopus 로고
    • Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 tesla
    • Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 tesla. Magn Reson Med 1994;32:335-341
    • (1994) Magn Reson Med , vol.32 , pp. 335-341
    • Ordidge, R.J.1    Gorell, J.M.2    Deniau, J.C.3    Knight, R.A.4    Helpern, J.A.5
  • 16
    • 0026736610 scopus 로고
    • Magnetic resonance imaging in Parkinson's disease: The evaluation of the width of pars compacta on T2 weighted images [in Japanese]
    • Moriwaka F, Tashiro K, Itoh K, Hamada T, Miyasaka K. Magnetic resonance imaging in Parkinson's disease: the evaluation of the width of pars compacta on T2 weighted images [in Japanese]. Rinsho Shinkeigaku 1992;32:8-12
    • (1992) Rinsho Shinkeigaku , vol.32 , pp. 8-12
    • Moriwaka, F.1    Tashiro, K.2    Itoh, K.3    Hamada, T.4    Miyasaka, K.5
  • 17
    • 0025390004 scopus 로고
    • Importance of magnetic resonance in Parkinson disease: An analytic study of the pars compacta
    • Mauricio JC, Coelho H, Sa J Martins A. Importance of magnetic resonance in Parkinson disease: an analytic study of the pars compacta. Acta Med Port 1990;3:85-88
    • (1990) Acta Med Port , vol.3 , pp. 85-88
    • Mauricio, J.C.1    Coelho, H.2    Martins, S.J.A.3
  • 18
    • 0023002982 scopus 로고
    • Magnetic resonance imaging of the midbrain in Parkinson's disease
    • Duguid JR, De La Paz R, DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986; 20:744-747
    • (1986) Ann Neurol , vol.20 , pp. 744-747
    • Duguid, J.R.1    De La Paz, R.2    DeGroot, J.3
  • 19
    • 0025954066 scopus 로고
    • Aging and Parkinson's disease: Substantia nigra regional selectivity
    • Fearnley JM, Lees AJ. Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301
    • (1991) Brain , vol.114 , pp. 2283-2301
    • Fearnley, J.M.1    Lees, A.J.2
  • 20
    • 0031668924 scopus 로고    scopus 로고
    • The early diagnosis of Parkinson's disease
    • Brooks DJ, The early diagnosis of Parkinson's disease. Ann Neurol 1998;44[suppl 1]:S10-S18
    • (1998) Ann Neurol , vol.44 , Issue.SUPPL. 1
    • Brooks, D.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.